Abstract
This chapter describes clinical findings, recommended laboratory investigations, and treatment options for acquired and inherited photosensitive skin disorders in pediatric patients. Photosensitive cutaneous disorders discussed include solar urticaria, polymorphous light eruption, juvenile spring eruption, actinic prurigo, hydroa vaccinoforme, pellagra, cutaneous porphyrias (erythropoietic protoporphyria, x-linked dominant protoporphyria, congenital erythropoietic porphyria, hepatoerythropoietic porphyria, porphyria cutanea tarda), and pseudoporphyria. Emphasis is placed on the approach to treatment of these conditions, and an annotated bibliography with evaluation of the strength of available evidence for various treatments is included.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Choi D, Kannan S, Lim HW. Evaluation of patients with photodermatoses. Dermatol Clin. 2014;32(3):267–75.
Monfrecola G1, Masturzo E, Riccardo AM, Balato F, Ayala F, Di Costanzo MP. Solar urticaria: a report on 57 cases. Am J Contact Dermat. 2000;11(2):89–94.
Monfrecola G, Masturzo E, Riccardo AM, Del Sorbo A. Cetirizine for solar urticaria in the visible spectrum. Dermatology. 2000;200(4):334–5.
Harris A, Burge SM, George SA. Solar urticaria in an infant. Br J Dermatol. 1997;136(1):105–7.
Calzavara-Pinton P, Zane C, Rossi M, Sala R, Venturini M. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2012;67(1):e5–9.
Roelandts R. Phototherapy of photodermatoses. J Dermatolog Treat. 2002;13(4):157–60.
Levi A, Enk CD. Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity. Photodermatol Photoimmunol Photomed. 2015;31(6):302–6.
Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2010;125(2):490–1.
Arasi S, Crisafulli G, Caminiti L, Guarneri F, Aversa T, Porcaro F, et al. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria. Pediatr Allergy Immunol. 2015;26(6):583–5.
Levi A, Tal Y, Dranitzki Z, Shalit M, Enk CD. Successful Omalizumab treatment of severe solar urticaria in a 6-year old child. Pediatr Allergy Immunol. 2015;26(6):588–90.
Hughes R, Cusack C, Murphy GM, Kirby B. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol. 2009;34(8):e660–2.
Mang R, Stege H, Budde MA, Ruzicka T, Krutmann J. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis) – a case report. Photodermatol Photoimmunol Photomed. 2002;18(4):196–8.
Haylett AK, Nie Z, Brownrigg M, Taylor R, Rhodes LE. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH. Br J Dermatol. 2011;164(2):407–14.
Ten Berge O, Sigurdsson V, Bruijnzeel-Koomen CA, van Weelden H, Pasmans SG. Photosensitivity testing in children. J Am Acad Dermatol. 2010;63(6):1019–25.
Schleyer V, Weber O, Yazdi A, Benedix F, Dietz K, Röcken M, et al. Prevention of polymorphic light eruption with a sunscreen of very high protection level against UVB and UVA radiation under standardized photodiagnostic conditions. Acta Derm Venereol. 2008;88(6):555–60.
Bissonnette R, Nigen S, Bolduc C. Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption. Photodermatol Photoimmunol Photomed. 2012;28(5):240–3.
Ortel B, Tanew A, Wolff K, Hönigsmann H. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol. 1986;14(5 Pt 1):748–53.
Dummer R, Ivanova K, Scheidegger EP, Burg G. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology. 2003;207(1):93–5.
Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JL. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol. 2000;143(4):828–31.
Marini A, Jaenicke T, Grether-Beck S, Le Floc’h C, Cheniti A, Piccardi N. Prevention of polymorphic light eruption by oral administration of a nutritional supplement containing lycopene, β-carotene, and Lactobacillus johnsonii: results from a randomized, placebo-controlled, double-blinded study. Photodermatol Photoimmunol Photomed. 2014;30(4):189–94.
Pareek A, Khopkar U, Sacchidanand S, Chandurkar N, Naik GS. Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study. Indian J Dermatol Venereol Leprol. 2008;74(1):18–22.
Saul A, Flores O, Novales J. Polymorphous light eruption: treatment with thalidomide. Australas J Dermatol. 1976;17(1):17–21.
Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol. 1986;115(1):77–80.
Rhodes LE, Durham BH, Fraser WD, Friedmann PS. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol. 1995;105(4):532–5.
Norris PG, Hawk JL. Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol. 1989;125(10):1377–9.
Caccialanza M, Percivalle S, Piccinno R, Brambilla R. Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses. Photodermatol Photoimmunol Photomed. 2007;23(1):46–7.
Hofer A, Legat FJ, Gruber-Wackernagel A, Quehenberger F, Wolf P. Topical liposomal DNA-repair enzymes in polymorphic light eruption. Photochem Photobiol Sci. 2011;10(7):1118–28.
Gruber-Wackernagel A, Bambach I, Legat FJ, Hofer A, Byrne SN, Quehenberger F, et al. Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D3 analogue in polymorphic light eruption. Br J Dermatol. 2011;165(1):152–63.
Hadshiew IM, Treder-Conrad C, v Bülow R, Klette E, Mann T, Stäb F, et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol Photoimmunol Photomed. 2004;20(4):200–4.
Berth-Jones J, Norris PG, Graham-Brown RA, Burns DA, Hutchinson PE, Adams J. Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol. 1991;124(4):375–8.
Stratigos AJ, Antoniou C, Papadakis P, Papapostolou A, Sabatziotis D, Tranaka K. Juvenile spring eruption: clinicopathologic features and phototesting results in 4 cases. J Am Acad Dermatol. 2004;50(2 Suppl):S57–60.
Ohshita A, Nakai N, Katoh N, Konishi K. Atypical case of juvenile spring eruption with photosensitivity to a single dose of ultraviolet A irradiation. J Dermatol. 2014;41(4):356–7.
Dogru S, Gungor A, Cekin E, Cincik H, Alga OH. Juvenile spring eruption: a report of two cases. Laryngoscope. 2006;116(7):1279–80.
Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, Domínguez-Soto L. Diagnosis and treatment of actinic prurigo. Dermatol Ther. 2003;16(1):40–4.
Herrera-Geopfert R, Magaña M. Follicular cheilitis. A distinctive histopathologic finding in actinic prurigo. Am J Dermatopathol. 1995;17(4):357–61.
Fusaro RM, Johnson JA. Topical photoprotection for hereditary polymorphic light eruption of American Indians. J Am Acad Dermatol. 1991;24(5 Pt 1):744–6.
Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol. 1995;132(6):956–63.
Les DY, Youn JI, Park MH, Chung JH. Actinic prurigo: limited effect of PUVA. Br J Dermatol. 1997;136(6):972–3.
Estrada-G I, Garibay-Escobar A, Núñez-Vázquez A, Hojyo-Tomoka T, Vega-Memije E, Cortés-Franco R. Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. Int J Dermatol. 2004;43(12):893–7.
Lane PR, Moreland AA, Hogan DJ. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report. Arch Dermatol. 1990;126(9):1211–3.
Torres-Alvarez B, Castanedo-Cazares JP, Moncada B. Pentoxifylline in the treatment of actinic prurigo. A preliminary report of 10 patients. Dermatology. 2004;208(3):198–201.
Durán MM, Ordoñez CP, Prieto JC, Bernal J. Treatment of actinic prurigo in Chimila Indians. Int J Dermatol. 1996;35(6):413–6.
Umaña A, Gómez A, Durán MM, Porras L. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporin A. Int J Dermatol. 2002;41(3):139–45.
Ortiz-Castillo JV, Boto-de-Los-Bueis A, De-Lucas-Laguna R, Pastor-Nieto B, Pelaez-Restrepo N, Fonseca-Sandomingo A. Topical cyclosporine in the treatment of ocular actinic prurigo. Arch Soc Esp Oftalmol. 2006;81:661–4.
Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2002;43(2):128–32.
Sunohara A, Mizuno N, Sakai M, Kawabe Y, Sakakibara S. Action spectrum for UV erythema and reproduction of the skin lesions in hydroa vacciniforme. Photodermatology. 1988;5(3):139–45.
Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):208–13.
Hirai Y, Yamamoto T, Kimura H, Ito Y, Tsuji K, Miyake T. Hydroa vacciniforme is associated with increased numbers of Epstein–barr virus–infected γδT cells. J Invest Dermatol. 2012;132(5):1401–8.
Wisuthsarewong W, Leenutaphong V, Viravan S. Hydroa vacciniforme with ocular involvement. J Med Assoc Thai. 1998;81(10):807–11.
Collins P, Ferguson J. Narrow-band UVB “(TL-01) phototherapy: an effective preventative treatment for the photodermatosesBr”. J Dermatol. 1995;132(6):956–63.
Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006;31(2):196–9.
Jaschke E, Hönigsmann H. Hydroa vacciniforme – action spectrum UV-tolerance following photochemotherapy. Hautarzt. 1981;32(7):350–3.
Sonnex TS, Hawk JLV. Hydroa vacciniforme: a review of ten cases. Br J Dermatol. 1988;118:101–8.
Lysell J, Wiegleb Edström D, Linde A, Carlsson G, Malmros-Svennilson J, Westermark A. Antiviral therapy in children with hydroa vacciniforme. Acta Derm Venereol. 2009;89(4):393–7.
Bruderer P, Shahabpour M, Christoffersen S, André J, Ledoux M. Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin. Dermatology. 1995;190(4):343–5.
Bickers DR, Demar LK, DeLeo V, Poh-Fitzpatrick MB, Aronberg JM, Harber LC. Hydroa vacciniforme. Arch Dermatol. 1978;114(8):1193–6.
Rhodes LE, White SI. Dietary fish oil as a photoprotective agent in hydroa vacciniforme. Br J Dermatol. 1998;138(1):173–8.
Brauns B, Seitz CS, Schon MP, Mempel M. Sunlight Induced papulovesicular eruption in 8 year-old girl. J Dtsch Dermatol Ges. 2012;10(12):923–4.
Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ. Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr. 2007;137(9):2013–7.
Piqué-Duran E, Pérez-Cejudo JA, Cameselle D, Palacios-Llopis S, García-Vázquez O. Pellagra: a clinical, histopathological, and epidemiological study of 7 cases. Actas Dermosifiliogr. 2012;103(1):51–8.
Ruffin JM, Smith DT. Pellagra therapy. Trans Am Clin Climatol Assoc. 1939;55:192–205.
Seal AJ, Creeke PI, Dibari F, Cheung E, Kyroussis E, Semedo P. Low and deficient niacin status and pellagra are endemic in postwar Angola. Am J Clin Nutr. 2007;85(1):218–24 [Erratum in: Am J Clin Nutr. 2009;89(4):1279].
Goldberger J, Wariu CH, Willets DG. Nutrition classics from Public Health Reports. The prevention of pellagra. A test of diet among institutional inmates. Nutr Rev. 1973;31(5):152–3.
Okan G, Yaylaci S, Alzafer S. Pellagra: will we see it more frequently? J Eur Acad Dermatol Venereol. 2009;23(3):365–6.
Vannucchi H, Moreno FS. Interaction of niacin and zinc metabolism in patients with alcoholic pellagra. Am J Clin Nutr. 1989;50(2):364–9.
Pellagra treated with tryptophan. [No authors listed]. Nutr Rev. 1987;45(5):142–8.
Comaish JS, Felix RH, McGrath H. Topically applied niacinamide in isoniazid-induced pellagra. Arch Dermatol. 1976;112(1):70–2.
Schulenburg-Brand D, Katugampola R, Anstey AV, Badminton MN. The cutaneous porphyrias. Dermatol Clin. 2014;32(3):369–84.
Holme SA, Anstey AV, Finlay AY, Elder GH, Badminton MN. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol. 2006;155(3):574–81.
Alemzadeh R, Feehan T. Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria. Eur J Pediatr. 2004;163(9):547–9.
Tu JH, Sheu SL, Teng JM. Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children. JAMA Dermatol. 2016 Jul 13. Epub ahead of print.
Katugampola RP, Anstey AV, Finlay AY, Whatley S, Woolf J, Mason N, et al. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. Br J Dermatol. 2012;167(4):888–900.
Bruce AJ, Ahmed I. Childhood-onset porphyria cutanea tarda: successful therapy with low-dose hydroxychloroquine (Plaquenil). J Am Acad Dermatol. 1998;38(5 Pt 2):810–4.
Boffa MJ, Ead RD, Reed P, Weinkove C. A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 1996;12(1):27–30.
Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey AV, Bissell DM, et al. Afamelanotide for Erythropoietic Protoporphyria. N Engl J Med. 2015;373(1):48–59.
Biolcati G, Marchesini E, Sorge F, Barbieri L, Schneider-Yin X, Minder EI. Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria. Br J Dermatol. 2015;172(6):1601–12.
Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermatol. 2001;44(1):100–8.
Mahon C, Purvis D, Laughton S, Bradbeer P, Teague L. Imatinib mesylate-induced pseudoporphyria in two children. Pediatr Dermatol. 2014;31(5):603–7.
Kwong WT, Hsu S. Pseudoporphyria associated with voriconazole. J Drugs Dermatol. 2007;6(10):1042–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Huang, Y.Y.M., Hunt, R.D. (2017). Photosensitivity and Photoreaction. In: Teng, J., Marqueling, A., Benjamin, L. (eds) Therapy in Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-43630-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-43630-2_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43628-9
Online ISBN: 978-3-319-43630-2
eBook Packages: MedicineMedicine (R0)